| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/26/2002 | WO2002074912A2 Tissue engineering enhanced by the transfer of a growth factor gene |
| 09/26/2002 | WO2002074805A1 Soluble rage protein |
| 09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
| 09/26/2002 | WO2002074345A2 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules |
| 09/26/2002 | WO2002074338A1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 09/26/2002 | WO2002074334A1 Mycrobacterial extract and its use in inflammatory bowel disease |
| 09/26/2002 | WO2002074333A2 Mycobacterial extracts used for treating allergy |
| 09/26/2002 | WO2002074330A2 Mycobacterrial estracts for treating autoimmune diseases |
| 09/26/2002 | WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 09/26/2002 | WO2002074234A2 Method and composition for treatment of skeletal dysplasias |
| 09/26/2002 | WO2002074158A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | WO2002074157A2 A mammalian immortalized liver cell |
| 09/26/2002 | WO2002074045A2 Production of pancreatic islet cells and delivery of insulin |
| 09/26/2002 | WO2002061420A3 Vitro in a cell interaction culture system for testing and developing medicaments |
| 09/26/2002 | WO2002053581A3 Spliceosome mediated rna trans-splicing |
| 09/26/2002 | WO2002053193A3 Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology |
| 09/26/2002 | WO2002036167A8 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/26/2002 | WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation |
| 09/26/2002 | WO2002022656A3 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 09/26/2002 | WO2002015918A3 Method and compositions for promoting osteogenesis |
| 09/26/2002 | WO2001047953A3 Antibodies against plasma cells |
| 09/26/2002 | WO2001032289A9 Methods for preparing blood or plasma component solutions with improved concentrations |
| 09/26/2002 | WO2001019977A9 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 09/26/2002 | WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use |
| 09/26/2002 | US20020138865 In vitro transfection, storage and transfer of male germ cells for generation of transgenic species & genetic therapies |
| 09/26/2002 | US20020137749 Formulation for menopausal women |
| 09/26/2002 | US20020137729 For minimizing the absorption of triglycerides and fats in the gastrointestinal tract; fat binding; treating obesity |
| 09/26/2002 | US20020137697 Chimeric receptor genes and cells transformed therewith |
| 09/26/2002 | US20020137667 Administering a therapeutically effective amount Trypanosoma cruzi trans-sialidase or a neurotrophic variant; amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Chagas' disease, peripheral neuropathy, |
| 09/26/2002 | US20020137666 Use of exendins and agonists thereof for the reduction of food intake |
| 09/26/2002 | US20020137204 Conditioned medium collected from a culture of feeder cells with laminin or collagen |
| 09/26/2002 | US20020137137 Genetic engineering; polypeptides |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020136778 1-100% high quality inedible egg, and milk product, cereal grain or product, fruit pectin, other carbohydrate, fiber, fat, urea, electrolyte, vitamin, mineral, yeast, and other animal protein and/or vegetable protein balance |
| 09/26/2002 | US20020136777 Three days old silkworms are freeze-dried, are powdered, extracted with methanol, and low pressure condensed, ginger extract, cinnamon bark extract, vitamin c, citric acid, and teurine |
| 09/26/2002 | US20020136769 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136705 Porcine spinal cord cells and their use in spinal cord repair |
| 09/26/2002 | US20020136704 Method for determining susceptibility of thymus in patient to activation through disruption of sex steroid signaling to thymus |
| 09/26/2002 | CA2460779A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 09/26/2002 | CA2441815A1 Method and composition for treatment of skeletal dysplasias |
| 09/26/2002 | CA2441740A1 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 09/26/2002 | CA2441564A1 Production of pancreatic islet cells and delivery of insulin |
| 09/26/2002 | CA2441289A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
| 09/26/2002 | CA2440844A1 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/25/2002 | EP1243278A2 Method of increasing the concentration of nitric oxide in blood |
| 09/25/2002 | EP1243275A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 09/25/2002 | EP1243274A2 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 09/25/2002 | EP1243273A1 Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
| 09/25/2002 | EP1243270A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 09/25/2002 | EP1243181A1 A probiotic, a food product containing a probiotic, a method for preparation of said food product, a pharmaceutical composition and a use of the probiotic strain |
| 09/25/2002 | EP1243180A1 A probiotic, a food product containing a probiotic, a method for preparation of said food product, a pharmaceutical composition and a use of the probiotic strain |
| 09/25/2002 | EP1242592A2 A molecular switch for regulating mammalian gene expression |
| 09/25/2002 | EP1242577A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242436A2 Oligosaccharide mixture |
| 09/25/2002 | EP1242157A1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 09/25/2002 | EP1242129A2 Biological joint construct |
| 09/25/2002 | EP1242116A2 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 09/25/2002 | EP1242105A2 Combination of ginseng and ginkgo to improve cognitive skills |
| 09/25/2002 | EP1242102A2 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 09/25/2002 | EP1242100A2 Regenerative adjuvant |
| 09/25/2002 | EP1242099A1 A method of treating infectious diseases |
| 09/25/2002 | EP1242098A2 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 09/25/2002 | EP1242050A2 Survivin promotion of angiogenesis |
| 09/25/2002 | EP1241939A1 Spore-like cells and uses thereof |
| 09/25/2002 | EP1146897B1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 09/25/2002 | EP0980263B1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 09/25/2002 | EP0806958A4 Inhibition of platelet binding |
| 09/25/2002 | EP0746325B1 Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation |
| 09/25/2002 | CN1371379A New indolocarbazole alkaloids from marine actinomycete |
| 09/25/2002 | CN1371289A Gene therapy using TGF-beta |
| 09/25/2002 | CN1371285A Methods and compounds for treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 09/25/2002 | CN1371283A Use of propionic bacteria for producing propionic acid and/or propionates in colon |
| 09/25/2002 | CN1371282A Medicaments that contain xenogenic oligo-or/and polyribonucleotides |
| 09/25/2002 | CN1371279A Metabolites of ecteinascidin 743 |
| 09/25/2002 | CN1370585A Composite Chinese medicine prepn for treating type II diabetes |
| 09/25/2002 | CN1370580A Chinese medicine for treating chronic salpingitis |
| 09/25/2002 | CN1370574A Antiphlogistic bolus made of honeysuckle, antelope horn and gentian |
| 09/25/2002 | CN1370569A Composite Chinese medicine powder for treating burns and scalds |
| 09/25/2002 | CN1370560A Intelligence growth promoting antilipenic nutritous health care soft capsule and its prepn |
| 09/25/2002 | CN1370559A Anti-senility antilipemic nutritious health care soft capsule and its prepn |
| 09/25/2002 | CN1370557A Ulcer treating capsule and its prepn |
| 09/25/2002 | CN1370554A Kidney-benefiting and tranquilizing medicine and its prepn |
| 09/25/2002 | CN1370553A Brain-invigorating tic-stopping medicine and its prepn |
| 09/25/2002 | CN1370544A Nutritious health care woodfrog egg oil caspule with blood lipoid reducing function and its prepn |
| 09/25/2002 | CN1370543A Antilipemic nutritious health care soft capsule and its prepn |
| 09/25/2002 | CN1370542A Heterogenous phaeochrome cell micrpcapsule and its prepn |
| 09/25/2002 | CN1370541A Chinese medicine prepn for treating schizophrenia |
| 09/25/2002 | CN1091382C Compound lingxian headache treating medicine and its preparation |
| 09/25/2002 | CN1091380C Preparation method of medicine huaqi huannao dan for curing encephalomyelopathy |
| 09/25/2002 | CN1091377C Labor inducing oral liquid and preparing process thereof |
| 09/25/2002 | CN1091376C Process for preparing medicine to treat prostatic diseases |
| 09/25/2002 | CN1091375C Nucleic acid hypoglycemic mixture |
| 09/25/2002 | CN1091374C External medicine for treating sore caused by shell wound or bullet wound |
| 09/25/2002 | CN1091367C Vanilla ointment matrix |
| 09/24/2002 | US6455311 Fabrication of vascularized tissue |
| 09/24/2002 | US6455306 Expanding culture of pure primitive hematopoieic cells in first bioreactor, culturing in second bioreactor to promote differentiation into erythroid cells, then culturing in third reactor to produce mature erythrocytes |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |